Drug Trial Radar · NCT06193889
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
66
Planned (sponsor's estimate)
Start
Aug 28, 2024
Primary completion
Sep 2027
Study completion Sep 2028
Sponsor
- Lead sponsor
- Kyverna TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis
Conditions
- Myasthenia Gravis
- Generalized Myasthenia Gravis
Interventions
Standard of Care TreatmentDrug
Standard of Care Medications Optional Crossover to receive KYV-101 treatment
Standard lymphodepletion regimenDrug
Standard lymphodepletion regimen
KYV-101Biological
Anti-CD19 CAR-T cell therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of adverse events (AEs) and laboratory abnormalities (Phase 2)Time frame: 18 months
- Efficacy of KYV-101 via Myasthenia Gravis Activities of Daily Living (MG-ADL) change from baseline (Phase 2)Time frame: 24 weeks
- Efficacy of KYV-101 via Myasthenia Gravis Activities of Daily Living (MG-ADL) change from baseline for KYV-101 Treatment arm to Standard of Care arm (Phase 3)Time frame: 24 weeks
- Efficacy of KYV-101 via Quantitative Myasthenia Gravis (QMG) change from baseline for KYV-101 Treatment arm to Standard of Care arm (Phase 3)Time frame: 24 weeks
Locations
22 sites in 6 countries. Site status is shown where the registry gives one.
Ronald Reagan UCLA Medical Center
Los Angeles, California · Recruiting
University of California, Irvine
Orange, California · Recruiting
Stanford University Medical Center
Palo Alto, California · Recruiting
University of Miami
Miami, Florida · Recruiting
Indiana University Health
Indianapolis, Indiana · Recruiting
University of Missouri
Columbia, Missouri · Recruiting
Oregon Health & Science University
Portland, Oregon · Recruiting
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania · Recruiting
Houston Methodist Hospital
Houston, Texas · Recruiting
Intermountain Medical Center
Murray, Utah · Recruiting
Westmead Institute for Medical Research
Westmead, Australia · Recruiting
Hospital Israelita Albert Einstein
São Paulo, Brazil · Recruiting
Charite- Universitätsklinikum Berlin
Berlin, Germany · Recruiting
Universitätsklinikum der Ruhr-Universität Bochum
Bochum, Germany · Recruiting
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany · Recruiting
Medizinische Hochscule Hannover
Hanover, Germany · Recruiting
Friedrich-Schiller-Universität Jena
Jena, Germany · Recruiting
Universitätsklinik Magdeburg
Magdeburg, Germany · Recruiting
Technical University Munich, Klinikum Rechts der Isar
Munich, Germany · Recruiting
King's Faisal Specialist Hospital and Research Center
Riyadh, Kindom of Saudi Arabia, Saudi Arabia · Recruiting
Cambridge University Hospital, Addenbrooke's Hospital
Cambridge, United Kingdom · Recruiting
King's College Hospital
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.